Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

On integrity in immunity during ontogeny or how thymic regulatory T cells work.

Dembic Z.

Scand J Immunol. 2019 Nov;90(5):e12806. doi: 10.1111/sji.12806. Epub 2019 Aug 13.

PMID:
31276223
2.

The case for allele-specific recognition by the TCR.

Cohn M, Anderson CC, Dembic Z.

Scand J Immunol. 2019 Aug;90(2):e12790. doi: 10.1111/sji.12790. Epub 2019 Jul 3.

PMID:
31127959
3.

Alternative Interleukin 17A/F Locus Haplotypes are Associated With Increased Risk to Hip and Knee Osteoarthritis.

Eftedal R, Vrgoc G, Jotanovic Z, Dembic Z.

J Orthop Res. 2019 Sep;37(9):1972-1978. doi: 10.1002/jor.24334. Epub 2019 May 20.

PMID:
31042000
4.

Interleukin-17 and Toll-like Receptor 10 genetic polymorphisms and susceptibility to large joint osteoarthritis.

Vrgoc G, Vrbanec J, Eftedal RK, Dembic PL, Balen S, Dembic Z, Jotanovic Z.

J Orthop Res. 2018 Jun;36(6):1684-1693. doi: 10.1002/jor.23823. Epub 2017 Dec 19.

5.

1-ethyl-3-(6-methylphenanthridine-8-il) urea modulates TLR3/9 activation and induces selective pro-inflammatory cytokine expression in vitro.

Teofilović NK, Bihi M, Stojković MR, Tumir LM, Ester K, Kralj M, Majhen D, Oršolić N, Lepur A, Vrbanec D, Markotić A, Dembić Z, Weber AN, Piantanida I, Vugrek O, Diken M, Knežević J.

Bioorg Med Chem Lett. 2017 Apr 1;27(7):1530-1537. doi: 10.1016/j.bmcl.2017.02.048. Epub 2017 Feb 20.

PMID:
28254484
6.

Immune Class Regulation and Its Medical Significance Part II of a Report of a Workshop on Foundational Concepts of Immune Regulation.

Bretscher PA, Corthay A, Anderson CC, Dembic Z, Havele C, Nagy ZA, Øynebråten I.

Scand J Immunol. 2017 Apr;85(4):242-250. doi: 10.1111/sji.12525.

7.

Immunological Tolerance. Part I of a Report of a Workshop on Foundational Concepts of Immune Regulation.

Anderson CC, Bretscher P, Corthay A, Dembic Z, Havele C, Nagy ZA, Øynebråten I.

Scand J Immunol. 2017 Feb;85(2):84-94. doi: 10.1111/sji.12500.

8.

HLA class II sequence variants influence tuberculosis risk in populations of European ancestry.

Sveinbjornsson G, Gudbjartsson DF, Halldorsson BV, Kristinsson KG, Gottfredsson M, Barrett JC, Gudmundsson LJ, Blondal K, Gylfason A, Gudjonsson SA, Helgadottir HT, Jonasdottir A, Jonasdottir A, Karason A, Kardum LB, Knežević J, Kristjansson H, Kristjansson M, Love A, Luo Y, Magnusson OT, Sulem P, Kong A, Masson G, Thorsteinsdottir U, Dembic Z, Nejentsev S, Blondal T, Jonsdottir I, Stefansson K.

Nat Genet. 2016 Mar;48(3):318-22. doi: 10.1038/ng.3498. Epub 2016 Feb 1.

9.

Association of the FAM46A gene VNTRs and BAG6 rs3117582 SNP with non small cell lung cancer (NSCLC) in Croatian and Norwegian populations.

Etokebe GE, Zienolddiny S, Kupanovac Z, Enersen M, Balen S, Flego V, Bulat-Kardum L, Radojčić-Badovinac A, Skaug V, Bakke P, Haugen A, Dembic Z.

PLoS One. 2015 Apr 17;10(4):e0122651. doi: 10.1371/journal.pone.0122651. eCollection 2015.

10.

Genetic Polymorphisms in the Toll-like Receptor 10, Interleukin (IL)17A and IL17F Genes Differently Affect the Risk for Tuberculosis in Croatian Population.

Bulat-Kardum LJ, Etokebe GE, Lederer P, Balen S, Dembic Z.

Scand J Immunol. 2015 Jul;82(1):63-9. doi: 10.1111/sji.12300.

11.

Polymorphisms in the interleukin-10 gene and chronic periodontitis in patients with atherosclerotic and aortic aneurysmal vascular diseases.

Armingohar Z, Jørgensen JJ, Kristoffersen AK, Schenck K, Dembic Z.

J Oral Microbiol. 2015 Feb 19;7:26051. doi: 10.3402/jom.v7.26051. eCollection 2015.

12.

Nagy, Zoltan, A.: A history of modern immunology: the path toward understanding.

Dembic Z.

Scand J Immunol. 2014 Nov 29. doi: 10.1111/sji.12260. [Epub ahead of print]

13.
14.

Susceptibility to large-joint osteoarthritis (hip and knee) is associated with BAG6 rs3117582 SNP and the VNTR polymorphism in the second exon of the FAM46A gene on chromosome 6.

Etokebe GE, Jotanovic Z, Mihelic R, Mulac-Jericevic B, Nikolic T, Balen S, Sestan B, Dembic Z.

J Orthop Res. 2015 Jan;33(1):56-62. doi: 10.1002/jor.22738. Epub 2014 Sep 18.

15.

How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?

Haabeth OA, Tveita AA, Fauskanger M, Schjesvold F, Lorvik KB, Hofgaard PO, Omholt H, Munthe LA, Dembic Z, Corthay A, Bogen B.

Front Immunol. 2014 Apr 15;5:174. doi: 10.3389/fimmu.2014.00174. eCollection 2014. Review.

16.

Association of variable number of tandem repeats in the coding region of the FAM46A gene, FAM46A rs11040 SNP and BAG6 rs3117582 SNP with susceptibility to tuberculosis.

Etokebe GE, Bulat-Kardum L, Munthe LA, Balen S, Dembic Z.

PLoS One. 2014 Mar 13;9(3):e91385. doi: 10.1371/journal.pone.0091385. eCollection 2014.

17.

Polymorphisms in the interleukin-1 gene locus and chronic periodontitis in patients with atherosclerotic and aortic aneurysmal vascular diseases.

Armingohar Z, Jørgensen JJ, Kristoffersen AK, Schenck K, Dembic Z.

Scand J Immunol. 2014 May;79(5):338-45. doi: 10.1111/sji.12166.

18.

Emerging pathways and promising agents with possible disease modifying effect in osteoarthritis treatment.

Jotanovic Z, Mihelic R, Sestan B, Dembic Z.

Curr Drug Targets. 2014 Jun;15(6):635-61.

PMID:
24597569
19.
20.

Associations of the interleukin-1 gene locus polymorphisms with risk to hip and knee osteoarthritis: gender and subpopulation differences.

Kaarvatn MH, Jotanovic Z, Mihelic R, Etokebe GE, Mulac-Jericevic B, Tijanic T, Balen S, Sestan B, Dembic Z.

Scand J Immunol. 2013 Feb;77(2):151-61. doi: 10.1111/sji.12016.

21.

Single nucleotide polymorphism in the interleukin 12B gene is associated with risk for breast cancer development.

Kaarvatn MH, Vrbanec J, Kulic A, Knezevic J, Petricevic B, Balen S, Vrbanec D, Dembic Z.

Scand J Immunol. 2012 Sep;76(3):329-35. doi: 10.1111/j.1365-3083.2012.02736.x.

22.

Heterozygous carriage of a dysfunctional Toll-like receptor 9 allele affects CpG oligonucleotide responses in B cells.

Knezević J, Pavlinić D, Rose WA 2nd, Leifer CA, Bendelja K, Gabrilovac J, Parcina M, Lauc G, Kubarenko AV, Petricevic B, Vrbanec D, Bulat-Kardum L, Bekeredjian-Ding I, Pavelić J, Dembić Z, Weber AN.

J Biol Chem. 2012 Jul 13;287(29):24544-53. doi: 10.1074/jbc.M111.337477. Epub 2012 May 21.

23.

Role of interleukin-1 inhibitors in osteoarthritis: an evidence-based review.

Jotanovic Z, Mihelic R, Sestan B, Dembic Z.

Drugs Aging. 2012 May 1;29(5):343-58. doi: 10.2165/11599350-000000000-00000. Review.

PMID:
22550965
24.

Association studies of gene polymorphisms in toll-like receptors 2 and 4 in Croatian patients with acute myocardial infarction.

Džumhur A, Zibar L, Wagner J, Simundić T, Dembić Z, Barbić J.

Scand J Immunol. 2012 May;75(5):517-23. doi: 10.1111/j.1365-3083.2012.02681.x.

25.

Hip osteoarthritis susceptibility is associated with IL1B -511(G>A) and IL1 RN (VNTR) genotypic polymorphisms in Croatian Caucasian population.

Jotanovic Z, Etokebe GE, Mihelic R, Heiland Kårvatn M, Mulac-Jericevic B, Tijanic T, Balen S, Sestan B, Dembic Z.

J Orthop Res. 2011 Aug;29(8):1137-44. doi: 10.1002/jor.21378. Epub 2011 Feb 24.

26.

IL1B -511(G>A) and IL1RN (VNTR) allelic polymorphisms and susceptibility to knee osteoarthritis in Croatian population.

Jotanovic Z, Etokebe GE, Mihelic R, Kaarvatn MH, Mulac-Jericevic B, Tijanic T, Balen S, Sestan B, Dembic Z.

Rheumatol Int. 2012 Jul;32(7):2135-41. doi: 10.1007/s00296-011-1946-3. Epub 2011 Apr 27.

PMID:
21523343
27.

My Basel Institute for Immunology, my BII, my bias.

Dembic Z.

Scand J Immunol. 2011 Jun;73(6):505-7. doi: 10.1111/j.1365-3083.2011.02552.x. No abstract available.

28.

Toll-like receptor 2 (P631H) mutant impairs membrane internalization and is a dominant negative allele.

Etokebe GE, Skjeldal F, Nilsen N, Rodionov D, Knezevic J, Bulat-Kardum L, Espevik T, Bakke O, Dembic Z.

Scand J Immunol. 2010 May;71(5):369-81. doi: 10.1111/j.1365-3083.2010.02379.x.

29.

Single-nucleotide polymorphisms in genes encoding toll-like receptor -2, -3, -4, and -9 in case-control study with breast cancer.

Etokebe GE, Knezević J, Petricević B, Pavelić J, Vrbanec D, Dembić Z.

Genet Test Mol Biomarkers. 2009 Dec;13(6):729-34. doi: 10.1089/gtmb.2009.0045.

PMID:
19810822
30.

Family-with-sequence-similarity-46, member A (Fam46a) gene is expressed in developing tooth buds.

Etokebe GE, Küchler AM, Haraldsen G, Landin M, Osmundsen H, Dembic Z.

Arch Oral Biol. 2009 Nov;54(11):1002-7. doi: 10.1016/j.archoralbio.2009.08.005. Epub 2009 Sep 8.

PMID:
19740458
31.

Beginning of the end of (understanding) the immune response.

Dembic Z.

Scand J Immunol. 2008 Oct;68(4):381-2. doi: 10.1111/j.1365-3083.2008.02159.x.

32.
33.

Interferon-gamma receptor-1 gene promoter polymorphisms (G-611A; T-56C) and susceptibility to tuberculosis.

Bulat-Kardum L, Etokebe GE, Knezevic J, Balen S, Matakovic-Mileusnic N, Zaputovic L, Pavelic J, Beg-Zec Z, Dembic Z.

Scand J Immunol. 2006 Feb;63(2):142-50.

34.

Interferon-gamma gene (T874A and G2109A) polymorphisms are associated with microscopy-positive tuberculosis.

Etokebe GE, Bulat-Kardum L, Johansen MS, Knezevic J, Balen S, Matakovic-Mileusnic N, Matanic D, Flego V, Pavelic J, Beg-Zec Z, Dembic Z.

Scand J Immunol. 2006 Feb;63(2):136-41.

36.
37.

Transcriptional activation of the SH2D2A gene is dependent on a cyclic adenosine 5'-monophosphate-responsive element in the proximal SH2D2A promoter.

Dai KZ, Johansen FE, Kolltveit KM, Aasheim HC, Dembic Z, Vartdal F, Spurkland A.

J Immunol. 2004 May 15;172(10):6144-51.

38.

Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models.

Corthay A, Lundin KU, Munthe LA, Frøyland M, Gedde-Dahl T, Dembic Z, Bogen B.

Cancer Immunol Immunother. 2004 Sep;53(9):759-69. Epub 2004 Apr 15. Review.

PMID:
15088126
39.

Polymorphisms in an interferon-gamma receptor-1 gene marker and susceptibility to periodontitis.

Fraser DA, Loos BG, Boman U, van Winkelhoff AJ, van der Velden U, Schenck K, Dembic Z.

Acta Odontol Scand. 2003 Oct;61(5):297-302.

PMID:
14763782
40.

Critical elements in case-control studies in predisposition to tuberculosis.

Dembic Z.

Scand J Immunol. 2003 Oct;58(4):386. No abstract available.

41.

Liver metastasis of cancer facilitated by chemokine receptor CCR6.

Dellacasagrande J, Schreurs OJ, Hofgaard PO, Omholt H, Steinsvoll S, Schenck K, Bogen B, Dembic Z.

Scand J Immunol. 2003 Jun;57(6):534-44.

42.

Interferon-gamma receptor-1 gene polymorphism in tuberculosis patients from Croatia.

Fraser DA, Bulat-Kardum L, Knezevic J, Babarovic P, Matakovic-Mileusnic N, Dellacasagrande J, Matanic D, Pavelic J, Beg-Zec Z, Dembic Z.

Scand J Immunol. 2003 May;57(5):480-4.

43.

Phagocytic dendritic cells from myelomas activate tumor-specific T cells at a single cell level.

Dembic Z, Røttingen JA, Dellacasagrande J, Schenck K, Bogen B.

Blood. 2001 May 1;97(9):2808-14.

PMID:
11313275
44.

Second International Conference on Signal Transduction, Croatia May 2000.

Dembic Z.

Scand J Immunol. 2000 Dec;52(6):641-3. No abstract available.

45.

Second International Conference on Signal Transduction, Croatia May 2000.

Dembic Z.

Scand J Immunol. 2000 Dec;52(6):641-3. No abstract available.

46.

Immune system protects integrity of tissues.

Dembic Z.

Mol Immunol. 2000 Aug;37(10):563-9.

PMID:
11163392
47.

Deletion of idiotype (Id)-specific T cells in multiple myeloma.

Bogen B, Schenck K, Munthe LA, Dembic Z.

Acta Oncol. 2000;39(7):783-8.

PMID:
11145433
48.

Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells.

Dembic Z, Schenck K, Bogen B.

Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2697-702.

50.

Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in mice.

Lu B, Ebensperger C, Dembic Z, Wang Y, Kvatyuk M, Lu T, Coffman RL, Pestka S, Rothman PB.

Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8233-8.

Supplemental Content

Loading ...
Support Center